Casein Kinase Inhibitors

CK1

CK2

Casein Kinase Inhibitors, Chemicals, Degraders, Substrates & Ligands

Product Name	CK1	CK2	Purity
IWP-2	CK1γ2, IC₅₀: 40 nM		99.93%
Silmitasertib		CK2α, IC₅₀: 1 nM CK2α', IC₅₀: 1 nM	99.92%
Emodin		CK2α Wild-type, IC₅₀: 5.9 μM (at ATP concentration is 50 μM) CK2α Wild-type, IC₅₀: 1.4 μM (at ATP concentration is 10 μM)	99.25%
Ellagic acid		CK2, IC₅₀: 40 nM	99.75%
SB-405483	CK1α		99.33%
IWP-4 (GMP)	CK1δ, IC₅₀: 1.06 μM CK1ε, IC₅₀: 7.07 μM
D4476	CK1, IC₅₀: 0.3 μM		99.89%
LY294002 hydrochloride		CK2, IC₅₀: 0.098 μM CK2α2, IC₅₀: 3.869 μM	99.97%
PF-670462 dihydrochloride	CK1δ, IC₅₀: 14 nM		99.96%
TBB		CK2, IC₅₀: 0.15 μM (Human CK2)	98.54%
Silmitasertib sodium salt		CK2α, IC₅₀: 1 nM CK2α', IC₅₀: 1 nM	99.92%
BTX-A51	CK1α/CSNK1A1		98.58%
FPFT-2216	CK1α		99.75%
SGC-CK2-1		CK2α, IC₅₀: 36 nM CK2α', IC₅₀: 16 nM	99.87%
SR-3029	CK1δ, IC₅₀: 44 nM		99.73%
PF-4800567	CK1δ, IC₅₀: 711 nM		99.69%
AMG-548 dihydrochloride	CK1		99.86%
DMAT		CK2, IC₅₀: 0.13 μM (Human CK2)	98.13%
DEG-77	CK1α, DC₅₀: 10 nM		99.03%
PF-5006739	CK1γ2, IC₅₀: 3.9 nM		99.56%
TAK-715	CK1γ2 CK1ε		99.76%
TMX-4116	CK1α		99.76%
IC261	CK1δ, IC₅₀: 1 μM CK1α1, IC₅₀: 16 μM		99.63%
BioE-1115		CK2α, IC₅₀: 10 μM	98.17%
Hematein		CKII, IC₅₀: 0.74 μM
BAY-204	CK1α1, IC₅₀: 2 nM (2 nM ATP) CK1α1, IC₅₀: 12 nM (1 mM ATP)		99.94%
CKI-7 free base	CK1, IC₅₀: 6 μM CK1, Ki: 8.5 μM		99.31%
CK1-IN-2	CK1α/CSNK1A1, IC₅₀: 123 nM		99.20%
AMG-548	CK1		≥99.0%
MU1742	CK1δ		99.54%
CK2/ERK8-IN-1		CK2, IC₅₀: 0.5 μM CK2, Ki: 0.25 μM	99.0%
Longdaysin	CK1α/CSNK1A1, IC₅₀: 5.6 μM CK1δ, IC₅₀: 8.8 μM		99.83%
CK1-IN-1	CK1δ, IC₅₀: 15 nM CK1ε, IC₅₀: 16 nM		99.19%
Casein Kinase 2 Substrate Peptide		CK2	98.91%
CK2 inhibitor 2		CK2, IC₅₀: 0.66 nM	98.51%
TBCA		CK2, IC₅₀: 110 nM CK2, Ki: 77 nM	99.45%
TTP 22		CK2, IC₅₀: 100 nM	98.40%
PI-828		CK2, IC₅₀: 149 nM CK2α2, IC₅₀: 1.127 μM	99.62%
TA-01	CK1δ, IC₅₀: 6.8 nM		99.86%
ON 108600		CK2α2, IC₅₀: 0.005 μM CK2α1, IC₅₀: 0.05 μM	98.65%
Quinalizarin		CK2, Ki: ~50 nM
CKI-7	CK1, IC₅₀: 6 μM CK1, Ki: 8.5 μM		99.97%
LH846	CK1δ, IC₅₀: 290 nM CK1α/CSNK1A1, IC₅₀: 2.5 μM		98.89%
TMX-4113	CK1α		99.08%
AH078	CK1δ, DC₅₀: 0.55 μM		99.73%
Emodin (Standard)		CK2α Wild-type
BRD4/CK2-IN-1		CK2, IC₅₀: 230 nM	98.21%
Casein Kinase inhibitor A86	CK1α/CSNK1A1		99.26%
MGD-28	CK1α, DC₅₀: 7.8 nM		99.73%
Rhodiolin	CK1ε		98%
SRPIN803		CK2, IC₅₀: 203 nM	99.70%
(R)-DRF053 dihydrochloride	CK1, IC₅₀: 14 nM		99.30%
QXG-6442	CK1α, DC₅₀: 5.7 nM		99.52%
Casein kinase 1δ-IN-3	CK1δ, pIC₅₀: 6.5376 M		99.50%
WH-10417-099	CK1		98.14%
MRT00033659	CK1δ, IC₅₀: 0.9 μM		99.77%
Casein kinase 1δ-IN-1	CK1δ		99.91%
NCC007	CK1α/CSNK1A1, IC₅₀: 1.8 μM CK1δ, IC₅₀: 3.6 μM		99.22%
KDX1381		CK2α, IC₅₀: 17 nM
SR-1277	CK1δ, IC₅₀: 49 nM		99.51%
A-3 hydrochloride	CK1, Ki: 80 μM	CK2, Ki: 5.1 μM	99.75%
PF-670462	CK1δ CK1ε		99.24%
APL-5125		CK2α, IC₅₀: 0.348 nM CK2α, Ki: 0.095 nM
MD-4251	CK1α
Casein kinase 1δ-IN-9	CK1γ2		98.0%
IQA		CK2
Casein Kinase II Receptor Peptide		CK2, Km: 500 μM
CK1δ-IN-10	CK1γ2, IC₅₀: 0.255 μM
CK2-IN-15		CK2α, IC₅₀: 51 pM
Casein kinase 1δ-IN-27	CK1ε, IC₅₀: 9.41 nM CK1γ2, IC₅₀: 16.5 nM CK1α, IC₅₀: 22 nM
CK2 Substrate peptide		CK2
CK2-IN-3		CK2α, IC₅₀: 1.51 μM CK2α', IC₅₀: 7.64 μM
Ellagic acid hydrate		CK2, Ki: 20 nM CK2, IC₅₀: 40 nM
Casein kinase 1δ-IN-29	CK1δ, IC₅₀: 0.005 μM CK1ε, IC₅₀: 0.447 μM
Casein kinase 1δ-IN-4	CK1γ2		98.0%
SR-4133	CK1ε, IC₅₀: 58 nM CK1γ2, IC₅₀: 10 μM
GSK-3β/CK-1δ-IN-1	CK1γ3, IC₅₀: 0.57 μM
BMS-159		CK2
CK2-IN-13		CK2, IC₅₀: 5.8 nM
FP1-24	CK1γ1, IC₅₀: 40 nM CK1γ2, IC₅₀: 10 nM CK1γ3, IC₅₀: 10 nM CK1δ, IC₅₀: 40 nM
CK1δ/CK1ε liagnd-1	CK1δ CK1ε
PIM-1/CK2-IN-2		CK2
Casein kinase 1δ-IN-10	CK1γ2
TID43		CK2, IC₅₀: 0.3 μM
CK1-IN-3	CK1γ2, IC₅₀: 2.22 μM		99.00%
IBA-11	CK1α
AH081	CK1δ CK1ε
CK2/PIM1-IN-1		CK2, IC₅₀: 3.787 μM
CK1-IN-4	CK1δ, IC₅₀: 2.74 μM
Casein kinase 1δ-IN-16	CK1δ
PF-5236216	CK1δ, IC₅₀: 8 nM CK1ε, IC₅₀: 36 nM
BMS-135		CK2α, IC₅₀: 0.8 nM CK2α', IC₅₀: 0.3 nM
CK1γ-IN-1	CK1γ1, IC₅₀: 780 nM CK1γ2, IC₅₀: 570 nM CK1γ3, IC₅₀: 990 nM
AMG-548 hydrochloride	CK1
CK2-TN03		CK2, IC₅₀: 165 nM	98.02%
IOR-160		CK2, IC₅₀: 1.7 nM
CK1δ-IN-3	CK1δ
CK2 inhibitor 4		CK2, IC₅₀: 3.8 μM
MU1742-amide-C6-acid	CK1δ CK1ε
Casein kinase 1δ-IN-28	CK1ε, IC₅₀: 14.6 nM
(E/Z)-Chk2-IN-1	CK1δ
CK1α-IN-1	CK1α, IC₅₀: 10.96 nM
EGFR-IN-57		CK2α, IC₅₀: 0.171 μM
Casein kinase 1δ-IN-15	CK1γ2, IC₅₀: 0.045 μM
SR-2890	CK1δ, IC₅₀: 4 nM CK1ε, IC₅₀: 44 nM CK1ε, Ki: 14 nM
CKS peptide	CK1
WAY-606344	CK1γ2
Multi-kinase-IN-6		CK2, IC₅₀: 0.09 μM
Casein kinase 1δ-IN-5	CK1γ2, IC₅₀: 47 nM
Casein kinase 1δ-IN-17	CK1δ
Casein kinase 1δ-IN-18	CK1δ
HDAC/CK2-IN-1		CK2, IC₅₀: 3.67 μM
CK1δ-IN-9	CK1δ, IC₅₀: 1.4 nM
CAM4066		CK2α, IC₅₀: 300 nM
CX-5279		CK2α, IC₅₀: 0.91 nM
TMCB		CK2α, Ki: 83 nM CK2α', Ki: 21 nM
CK2 inhibitor 3		CK2, IC₅₀: 280 nM
Casein kinase 1δ-IN-31	CK1γ2, IC₅₀: 17 nM CK1α, IC₅₀: 196 nM
p38α inhibitor 8	CK1γ2, IC₅₀: 0.202 μM
4,5,6,7-Tetrabromo-1H-benzimidazole		CK2
CK2-IN-14		CK2, IC₅₀: 0.66 nM
CK2-IN-12		CK2, IC₅₀: 0.8 μM	99.74%
CSNK2-IN-2		CK2

Name
Email *

	Sorry, but the email address you supplied was invalid.